Programmable RNA base editing with photoactivatable CRISPR-Cas13

被引:4
|
作者
Yu, Jeonghye [1 ]
Shin, Jongpil [1 ]
Yu, Jihwan [1 ]
Kim, Jihye [1 ]
Yu, Daseuli [2 ]
Heo, Won Do [1 ,3 ]
机构
[1] Korea Adv Inst Sci & Technol KAIST, Dept Biol Sci, Daejeon, South Korea
[2] Korea Adv Inst Sci & Technol, Life Sci Res Inst, Daejeon, South Korea
[3] Korea Adv Inst Sci & Technol, KAIST Inst BioCentury KIB, Daejeon, South Korea
基金
新加坡国家研究基金会;
关键词
SYSTEM; EVOLUTION;
D O I
10.1038/s41467-024-44867-2
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
CRISPR-Cas13 is widely used for programmable RNA interference, imaging, and editing. In this study, we develop a light-inducible Cas13 system called paCas13 by fusing Magnet with fragment pairs. The most effective split site, N351/C350, was identified and found to exhibit a low background and high inducibility. We observed significant light-induced perturbation of endogenous transcripts by paCas13. We further present a light-inducible base-editing system, herein called the padCas13 editor, by fusing ADAR2 to catalytically inactive paCas13 fragments. The padCas13 editor enabled reversible RNA editing under light and was effective in editing A-to-I and C-to-U RNA bases, targeting disease-relevant transcripts, and fine-tuning endogenous transcripts in mammalian cells in vitro. The padCas13 editor was also used to adjust post-translational modifications and demonstrated the ability to activate target transcripts in a mouse model in vivo. We therefore present a light-inducible RNA-modulating technique based on CRISPR-Cas13 that enables target RNAs to be diversely manipulated in vitro and in vivo, including through RNA degradation and base editing. The approach using the paCas13 system can be broadly applicable to manipulating RNA in various disease states and physiological processes, offering potential additional avenues for research and therapeutic development. Cas13 systems suffer from a lack of spatiotemporal control. Here the authors report paCas13, a light-inducible Cas13 system created by fusing Magnet with fragment pairs; they also report padCas13, a light-inducible base-editing system by fusing ADAR2 to catalytically inactive paCas13 fragments.
引用
收藏
页数:14
相关论文
共 50 条
  • [1] Programmable RNA base editing with photoactivatable CRISPR-Cas13
    Jeonghye Yu
    Jongpil Shin
    Jihwan Yu
    Jihye Kim
    Daseuli Yu
    Won Do Heo
    [J]. Nature Communications, 15
  • [2] RNA editing with CRISPR-Cas13
    Cox, David B. T.
    Gootenberg, Jonathan S.
    Abudayyeh, Omar O.
    Franklin, Brian
    Kellner, Max J.
    Joung, Julia
    Zhang, Feng
    [J]. SCIENCE, 2017, 358 (6366) : 1019 - 1027
  • [3] Photoactivatable RNA N6-Methyladenosine Editing with CRISPR-Cas13
    Zhao, Jie
    Li, Bing
    Ma, Jianxiong
    Jin, Weilin
    Ma, Xinlong
    [J]. SMALL, 2020, 16 (30)
  • [4] Commentary: RNA editing with CRISPR-Cas13
    Matsoukas, Ianis G.
    [J]. FRONTIERS IN GENETICS, 2018, 9
  • [5] Programmable RNA targeting with CRISPR-Cas13
    Shi, Peiguo
    Wu, Xuebing
    [J]. RNA BIOLOGY, 2024, 21 (01) : 1 - 9
  • [6] Programmable RNA editing with compact CRISPR-Cas13 systems from uncultivated microbes
    Xu, Chunlong
    Zhou, Yingsi
    Xiao, Qingquan
    He, Bingbing
    Geng, Guannan
    Wang, Zikang
    Cao, Birong
    Dong, Xue
    Bai, Weiya
    Wang, Yifan
    Wang, Xiang
    Zhou, Dongming
    Yuan, Tanglong
    Huo, Xiaona
    Lai, Jinsheng
    Yang, Hui
    [J]. NATURE METHODS, 2021, 18 (05) : 499 - +
  • [7] RNA Editing for Usher Syndrome Using CRISPR-Cas13
    Fry, Lewis E.
    Barnard, Alun R.
    McClements, Michelle E.
    MacLaren, Robert E.
    [J]. MOLECULAR THERAPY, 2020, 28 (04) : 478 - 479
  • [8] RNA targeting with CRISPR-Cas13
    Abudayyeh, Omar O.
    Gootenberg, Jonathan S.
    Essletzbichler, Patrick
    Han, Shuo
    Joung, Julia
    Belanto, Joseph J.
    Verdine, Vanessa
    Cox, David B. T.
    Kellner, Max J.
    Regev, Aviv
    Lander, Eric S.
    Voytas, Daniel F.
    Ting, Alice Y.
    Zhang, Feng
    [J]. NATURE, 2017, 550 (7675) : 280 - +
  • [9] Comparison of CRISPR-Cas13 RNA editing tools for inherited retinal disease
    Fry, Lewis E.
    McClements, Michelle E.
    MacLaren, Robert E.
    [J]. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2022, 63 (07)
  • [10] Insights Gained from RNA Editing Targeted by the CRISPR-Cas13 Family
    Liu, Li
    Pei, De-Sheng
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (19)